Halden Zimmermann began his career in manufacturing as an engineer for ITT Automotive, a Global Tier 1 components manufacturer supplying electronics systems to major automotive companies like GM, Toyota, Honda and BMW. During this time, his role expanded from manufacturing engineering and product development, to continuous improvement / quality and then plant management focused on turnaround and consolidation of facilities. At ITT, he was the first to be supported and nominated for a company sponsored MBA program at the University of Rochester, Simon School of Business as part of his leadership track training, and the youngest to be accepted to University program in its history.
Soon after graduation, Halden found himself following the President of ITT Automotive to Alcan to focus on global operational restructuring and continuous improvement. After exposure to many aspects of the business and finishing the Alcan corporate leadership development program, Halden relocated to Paris, France in a Global Marketing role. He worked directly for the CEO of the packaging business and focused on leading and transitioning the commercial organization to a value based dynamic function. The value based marketing concept became the standard for the entire company and he led the global roll out to 5 continents.
After the acquisition of Alcan, Halden Zimmermann transitioned to the healthcare market by leading a business unit at Cardinal Health. He became the Director for the Mail Order Pharmaceutical and Alternate Care Services space, where he led the strategy development to tactics execution driving significant growth of the business. At the start, the $4.9b dollar P and L business had not won a deal in five years and its share was declining in a growing market. He implemented a focused strategy to drive marketing and sales, built a value added consultative service organization from scratch, which turned the business around and revenue grew to $8.9b in 2 years.
Halden was then promoted to lead Marketing and Pricing strategy for the Medical Products business, where he had ownership of strategy and long term growth for the $9 billion dollar supply, capital medical equipment, and laboratory solutions business. He transitioned the business from a cost plus business to a value based offering business, enveloping products with value added services to grow margins and increase sales through differentiation. Some of the most successful pricing strategies were used as a competitive advantage, and Halden’s many service-based patents and offers are still in use today.
Currently, Halden Zimmermann is the Vice President and General Manager for Leica Microsystems. Leica is an operating company of Danaher concentrated on industrial technologies, medical / surgical capital and life science research imaging solutions. Halden was initially brought in to reshape Leica’s approach to marketing and spur organic growth in an acquisitive intense environment. Some of the best practices implemented have been shared across the Danaher platforms and are in use today. Halden was then given additional responsibility as P and L leader for one of Leica’s largest advanced capital businesses. By creating a focused strategy, converting to an aggressive hunting organization, improving feet on the street and restructuring to take cost out; the results were 10pts of share gain and operating profit improvement of 50%.